Nasdaq · CIK 0001830033
PCT PureCycle Technologies, Inc.
Insider trading from SEC Form 4. Last filing 18 d ago. Close $3.92 on Oct 9, 2026, +3% from the 52-week low and -74% from the high.
PureCycle Technologies, Inc. (PCT) has 54 SEC Form 4 filings on file from 15 insiders, the latest filed on Sep 25, 2026. In the last 90 days insiders made 1 open-market buy worth $99k and 0 open-market sells worth $0, net +$99k.
2 open-market trades have been scored at PCT. The newest: Fernando Musa (director) bought $99k of stock on Sep 4, 2026, filed Sep 8, 2026, scored 28 (weak). The largest of the 2 shown: Sylebra Capital LLC (10% owner) bought $5.0M on Feb 6, 2025, scored 32 (weak).
PCT closed at $3.92 on Oct 9, 2026, 3% above its 52-week low and 74% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at PureCycle Technologies, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Fernando Musa director buy | $99k 15,479 shares | +10% | - | |
| 32Weak | Sylebra Capital LLC owner buy | $5.0M 619,925 shares | +2% | - |
Transactions
The newest 50 of 66 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -2,830 | $5.15 | $15k | 130,497 | 18 d ago |
| Sep 4, 2026 | Fernando Musa director | POpen-market purchase Common Stock | +15,479 | $6.38 | $99k | 175,983 | 35 d ago |
| Mar 22, 2026 | Donald Carpenter Chief Financial Officer | FTax withholding Common Stock | -1,356 | $5.79 | $7,851 | 135,539 | Jul 23, 2026 |
| Jun 15, 2026 | Sylebra Capital LLC director, owner | DDisposition to issuer 7.25% Green Convertible Senior Notes due 2030derivativeindirect: See Footnotes (1) and (2) | - | $1,050.00 | - | 0 | Jun 16, 2026 |
| May 20, 2026 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -2,141 | $11.86 | $25k | 1,321,109 | May 21, 2026 |
| May 20, 2026 | Donald Carpenter Chief Financial Officer | FTax withholding Common Stock | -3,017 | $11.86 | $36k | 96,564 | May 21, 2026 |
| May 12, 2026 | Daniel M Coombs director | AGrant or award Common Stock | +16,622 | $0.00 | $0 | 156,843 | May 13, 2026 |
| May 12, 2026 | Siri Jirapongphan director | AGrant or award Common Stock | +16,622 | $0.00 | $0 | 21,171 | May 13, 2026 |
| May 12, 2026 | Allen Jacoby director | AGrant or award Common Stock | +16,622 | $0.00 | $0 | 96,088 | May 13, 2026 |
| May 12, 2026 | Valerie Anne Mars director | AGrant or award Common Stock | +16,622 | $0.00 | $0 | 21,320 | May 13, 2026 |
| May 12, 2026 | Fernando Musa director | AGrant or award Common Stock | +16,622 | $0.00 | $0 | 160,504 | May 13, 2026 |
| May 12, 2026 | Tanya Burnell director | AGrant or award Common Stock | +16,622 | $0.00 | $0 | 106,422 | May 13, 2026 |
| May 12, 2026 | Sylebra Capital LLC director, owner | POpen-market purchase Common Stockindirect: See Footnotes | +16,622 | $0.00 | $0 | 34,113,545 | May 13, 2026 |
| May 12, 2026 | Steven F Bouck director | AGrant or award Common Stock | +16,622 | $0.00 | $0 | 101,788 | May 13, 2026 |
| Mar 22, 2026 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -25,887 | $5.79 | $150k | 1,323,250 | Mar 24, 2026 |
| Mar 22, 2026 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -6,562 | $5.79 | $38k | 183,327 | Mar 23, 2026 |
| Mar 2, 2026 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -3,398 | $6.45 | $22k | 189,889 | Mar 3, 2026 |
| Mar 2, 2026 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -5,786 | $6.45 | $37k | 1,349,137 | Mar 3, 2026 |
| Feb 27, 2026 | Brad Kalter General Counsel, CCO & Scty. | AGrant or award Common Stock | +14,200 | $0.00 | $0 | 197,880 | Mar 2, 2026 |
| Feb 27, 2026 | Dustin Olson Chief Executive Officer | AGrant or award Common Stock | +46,052 | $0.00 | $0 | 1,373,044 | Mar 2, 2026 |
| Feb 27, 2026 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -4,593 | $6.31 | $29k | 193,287 | Mar 2, 2026 |
| Feb 27, 2026 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -18,121 | $6.31 | $114k | 1,354,923 | Mar 2, 2026 |
| Feb 20, 2026 | Gregory L Barta Corp. Controller and CAO | FTax withholding Common Stock | -870 | $8.99 | $7,821 | 17,441 | Feb 23, 2026 |
| Feb 20, 2026 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -2,841 | $8.99 | $26k | 188,588 | Feb 23, 2026 |
| Feb 20, 2026 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -12,131 | $8.99 | $109k | 1,351,592 | Feb 23, 2026 |
| Feb 20, 2026 | Jaime Vasquez Chief Financial Officer | FTax withholding Common Stock | -3,057 | $8.99 | $27k | 95,472 | Feb 23, 2026 |
| Feb 21, 2026 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -4,908 | $8.99 | $44k | 183,680 | Feb 23, 2026 |
| Feb 21, 2026 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -24,600 | $8.99 | $221k | 1,326,992 | Feb 23, 2026 |
| Feb 21, 2026 | Jaime Vasquez Chief Financial Officer | FTax withholding Common Stock | -5,594 | $8.99 | $50k | 89,878 | Feb 23, 2026 |
| Feb 17, 2026 | Brad Kalter General Counsel, CCO & Scty. | AGrant or award Common Stock | +34,580 | $0.00 | $0 | 191,429 | Feb 19, 2026 |
| Feb 17, 2026 | Dustin Olson Chief Executive Officer | AGrant or award Common Stock | +145,914 | $0.00 | $0 | 1,363,723 | Feb 19, 2026 |
| Feb 17, 2026 | Gregory L Barta Corp. Controller and CAO | AGrant or award Common Stock | +9,969 | $0.00 | $0 | 18,311 | Feb 19, 2026 |
| Feb 17, 2026 | Dustin Olson Chief Executive Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +109,170 | $0.00 | $0 | 109,170 | Feb 19, 2026 |
| Feb 17, 2026 | Gregory L Barta Corp. Controller and CAO | AGrant or award Employee Stock Option (Right to Buy)derivative | +7,459 | $0.00 | $0 | 7,459 | Feb 19, 2026 |
| Feb 17, 2026 | Brad Kalter General Counsel, CCO & Scty. | AGrant or award Employee Stock Option (Right to Buy)derivative | +25,872 | $0.00 | $0 | 25,872 | Feb 19, 2026 |
| Jan 1, 2026 | Valerie Anne Mars director | AGrant or award Common Stock | +4,698 | $0.00 | $0 | 4,698 | Jan 26, 2026 |
| Dec 22, 2025 | Fernando Musa director | JOther Common Stock | +66,716 | $0.00 | $0 | 143,882 | Dec 23, 2025 |
| Oct 28, 2025 | Siri Jirapongphan director | AGrant or award Common Stock | +4,549 | $0.00 | $0 | 4,549 | Nov 6, 2025 |
| Oct 30, 2025 | Jeffrey Richard Fieler director | DDisposition to issuer Common Stock | -9,675 | $0.00 | $0 | 1,973,428 | Nov 4, 2025 |
| Oct 30, 2025 | Jeffrey Richard Fieler director | FTax withholding Common Stock | -2,902 | $11.34 | $33k | 1,970,526 | Nov 4, 2025 |
| Sep 23, 2025 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -2,830 | $13.90 | $39k | 156,849 | Sep 24, 2025 |
| Aug 14, 2025 | Brad Kalter General Counsel, CCO & Scty. | OOut-of-the-money exercise Common Stock | -42,500 | $0.00 | $0 | 159,679 | Aug 15, 2025 |
| Aug 5, 2025 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -11,149 | $13.24 | $148k | 1,217,809 | Aug 6, 2025 |
| Jul 8, 2025 | Brad Kalter General Counsel, CCO & Scty. | FTax withholding Common Stock | -6,066 | $14.56 | $88k | 202,179 | Jul 9, 2025 |
| Jul 8, 2025 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -17,767 | $14.56 | $259k | 1,228,958 | Jul 9, 2025 |
| Jun 20, 2025 | Daniel Patrick Gibson director, owner | POpen-market purchase Series B Convertible Preferred Stockderivativeindirect: See Footnote | +40,000 | $1,000.00 | $40M | 40,000 | Jun 23, 2025 |
| Jun 16, 2025 | Dustin Olson Chief Executive Officer | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 1,325,425 | Jun 17, 2025 |
| Jun 16, 2025 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -78,700 | $11.87 | $934k | 1,246,725 | Jun 17, 2025 |
| May 20, 2025 | Dustin Olson Chief Executive Officer | FTax withholding Common Stock | -2,141 | $8.76 | $19k | 1,125,425 | May 22, 2025 |
| May 8, 2025 | Daniel Patrick Gibson director, owner | AGrant or award Common Stockindirect: See Footnote | +19,349 | $0.00 | $0 | 34,096,923 | May 12, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Steven F Bouckdirector
- Gregory L BartaCorp. Controller and CAO
- Tanya Burnelldirector
- Donald CarpenterChief Financial Officer
- Daniel M Coombsdirector
- Jeffrey Richard Fielerdirector
- Daniel Patrick Gibsondirector, owner
- Allen Jacobydirector
- Siri Jirapongphandirector
- Brad KalterGeneral Counsel, CCO & Scty.
- Valerie Anne Marsdirector
- Fernando Musadirector
- Dustin OlsonChief Executive Officer
- Sylebra Capital LLCowner, other, director
- Jaime VasquezChief Financial Officer
Questions about PCT
Answered from the filings on this page, as of the latest one.
Are insiders buying PCT?
As of Sep 25, 2026, SEC Form 4 filings show 1 open-market buy worth $99k by 1 insider and 0 open-market sells worth $0 by 0 insiders at PureCycle Technologies, Inc. in the last 90 days, net +$99k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade PCT on the open market?
Fernando Musa (director) bought $99k of PCT on Sep 4, 2026 and filed the Form 4 on Sep 8, 2026. InsiderTell scored 28 (weak).
How many insiders file Form 4 at PureCycle Technologies, Inc.?
15 people have filed a Form 4 at PureCycle Technologies, Inc., among them Steven F Bouck (director), Gregory L Barta (Corp. Controller and CAO), Tanya Burnell (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.